✨
AI Summary
- Lilly's Alzheimer's drug approved; challenges of late-stage ADCs.
- Eisai regains ADC control; RSV vaccine developer expectations decline.
- Interview with Amgen's Ian Thompson.
Guests on This Episode
IT
Ian Thompson
1 podcast appearance